Two major healthcare companies have recently released products that signal a tectonic shift in diabetes care. According to experts, these products can make a huge impact on the field of diabetes care.
Roche released the Accu-Chek Aviva Connect, their first wireless syncing glucometer and cloud platform for iPhone and Android in August. LifeScan introduced an app update to their Verio Sync wireless glucose meter for iPhone in November. The app enabled Apple HealthKit integration.
‘While Roche released the Accu-Chek Aviva Connect, their first wireless syncing glucometer in August, LifeScan introduced an app update to their Verio Sync wireless glucose meter for iPhone in November.’
The devices are nothing new for the advanced mechanical industry. In fact, the first glucose meter for iPhone called Agamatrix's iBG Star was launched in 2011. Since then, startups like iHealth, TelCare, and Livongo have released wireless glucose meters of their own. However, the fact is that very few users seek out such advanced glucose meters, instead using whatever meter their doctor handed them.
The Accu-chek Aviva Connect and Verio Sync utilize the same test strips as other non-wireless models, ensuring instantaneous, widespread insurance coverage.
In 2008, the two companies (Roche and Lifescan) owned 58% of the global diabetes monitoring market, and the top 4 brands (adding Bayer and Abbott) owned 90% of that market.